Blindness Risk Connected to Semaglutide Drugs for Diabetics and Obese Individuals – Study
Boston, Massachusetts – A recent study suggests that individuals with diabetes or obesity who take medications such as Ozempic or Wegovy may have a higher risk of developing a rare form of blindness called non-arteritic anterior ischemic optic neuropathy (NAION). While this potential side effect is concerning, experts urge patients not to discontinue their medication without consulting their healthcare provider. Last summer, doctors at Mass Eye and Ear in Boston observed an unusual surge in …